Tegaserod maleate
CAS: 189188-57-6
Ref. TM-T1551
10mg | 46,00 € | ||
25mg | 78,00 € | ||
50mg | 118,00 € | ||
100mg | 194,00 € | ||
200mg | 295,00 € | ||
500mg | 497,00 € | ||
1ml*10 (DMSO) | 50,00 € |
Informação sobre produto
- HTF-919, SDZ-HTF-919
- (2E)-2-[(5-methoxy-1H-indol-3-yl)methylidene]-N-pentylhydrazinecarboximidamide (2Z)-but-2-enedioate (1:1)
- 2-[(5-Methoxy-1H-Indole-3-Yl)Methylene]-N-Pentylcarbazimidamide Hydrogen Maleate
- 2-[(Z)-(5-methoxy-3H-indol-3-ylidene)methyl]-N'-pentylhydrazinecarboximidamide (2Z)-but-2-enedioate
- Htf 919
- Hydrazinecarboximidamide, 2-[(5-methoxy-1H-indol-3-yl)methylene]-N-pentyl-, (2Z)-2-butenedioate (1:1)
- Hydrazinecarboximidamide, 2-[(5-methoxy-1H-indol-3-yl)methylene]-N-pentyl-, (Z)-2-butenedioate (1:1)
- Sdz-Htf 919
- Tegaserod Maleate
- Tegaserod hydrogen maleate
- Ver mais sinónimos
- Tegaserode
- Tegibs 6
- Zelmac
- Zelnorm
Tegaserod maleate (SDZ-HTF-919) is a 5-HT4 agonist manufactured by Novartis and used for the management of irritable bowel syndrome and constipation. Its use was the only drug approved by the United States Food and Drug Administration to help relieve the abdominal discomfort, bloating and constipation associated with irritable bowel syndrome. On March 30, 2007, the U.S. Food and Drug Administration requested that Novartis withdraw Zelnorm from shelves. The FDA alleges a relationship between prescriptions of the drug and increased risks of heart attack or stroke.
Propriedades químicas
Consulta técnica sobre: TM-T1551 Tegaserod maleate
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.